Stay updated with the latest pharmaceutical-industry news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pharmaceutical-industry topics.
New Delhi, Sep 29 (PTI) The initial public offer of Fabtech Technologies Ltd, a turnkey engineering solutions provider for the pharmaceuticals, biotech and healthcare industry, received 70 per cent subscription on the first day of the share sale on Monday. The IPO got bids for 84,20,325 shares against 1,20,60,000 shares on offer, according to NSE data. The quota for qualified institutional buyers (QIBs) was subscribed 77 per cent, and the retail individual investors (RIIs) category received 70 ...Read More >
Mumbai, Sep 29 (PTI) Rupee consolidated in a narrow range and settled for the day lower by 7 paise at its all-time closing low of 88.79 (provisional) against US dollar on Monday, on persistent foreign capital outflows and rise in risk-off sentiments. Forex traders said rupee is hovering near its all-time low level as investors remained concerned over global trade uncertainties and impact of US visa fee hike on India's IT services exports. Moreover, the Reserve Bank of India (RBI) policy meetin ...Read More >
Mumbai, Sep 29 (PTI) Rupee rises 3 paise to 88.69 against the US dollar in early trade on Monday, tracking positive Asian currencies and weakness of the American currency in the overseas market. Forex traders said the rupee is trading in a tight range as it remains under pressure influenced by continued capital outflows and geo-political developments. Moreover, the RBI policy meeting outcome on October 1, is expected to influence the rupee and government bond movements. At the interbank forei ...Read More >
Mumbai, Sep 29 (SocialNews.XYZ) Shiv Sena(UBT) on Monday claimed that US President Trump has dealt a blow to Indian pharmaceutical companies by imposing a 100 per cent tariff on medicines, saying that it will devastate the Indian pharmaceutical industry and affect healthcare for the poor and middle class. "Trump, who is acting as if he is taking revenge on Indian business and industry, wants to destroy India's economy. He certainly wants to dent Prime Minister Narendra Modi's stated ambition to ...Read More >
For the month, FII sold equities worth Rs 30,141.68 crore, while DII bought equities worth Rs 55,736.09 crore. The broader indices broke a three-week gaining streak and underperformed the main indices as markets remained under pressure throughout the week on worries over fresh tariffs on pharma, higher visa fees by the US, persistent trade concerns, and continued FII selling. For the week, Nifty50 plunged 672.35 points or 2.65 percent to finish at 24,654.70, while the BSE Sensex index declined ...Read More >
New Delhi: A top member of Donald Trump's administration has hit out at India once again on the issue of trade imbalance, saying that it is one of the countries that needs 'fixing'. Such a remark from US commerce secretary Howard Lutnick threatens to put the ongoing trade talks between the two countries under stress. If India wishes to sell to American consumers, it will have to "play ball with the President", Lutnick said. Hitting out at India and Brazil, he said that these countries need to d ...Read More >
Chennai, Sep 27 (SocialNews.XYZ) Marumalarchi Dravida Munnetra Kazhagam (MDMK) general secretary Vaiko has warned that the United States' latest decision to impose a steep 100 per cent import duty on medicines could deal a severe blow to India's pharmaceutical exports and trigger a wider trade crisis. Quoting data from the World Trade Organization (WTO), Vaiko said pharmaceuticals form India's single largest industrial export segment. Each year, India ships about $12.7 billion worth of medicin ...Read More >
Mumbai, Sep 26 (SocialNews.XYZ) The Indian equity benchmarks ended this week with the steepest weekly decline in six months, as well as registering a sixth consecutive session of decline -- amid concerns over H-1B visa fee hike and US pharma tariffs. Nifty and Sensex ended with a decline of around 2.50 per cent and 2.54 per cent, respectively, even as IT and pharma sectors came under selling pressure. Midcap and small-cap indices witnessed even higher selling pressure due to stretched valuatio ...Read More >
Ministry of External Affairs (MEA) Official Spokesperson Randhir Jaiswal, reacting to US President Donald Trump's imposition of 100% tariffs on imports of branded and patented pharmaceutical drugs from October 1, 2025, said the government is monitoring the situation closely. On Thursday, the Trump administration announced that starting October 1, 2025, it will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufactu ...Read More >
New Delhi: India is engaged with the US and other stakeholders over the framing of rules for the Trump administration's move to levy a fee of $100,000 for H-1B visas, with the ministry of external affairs (MEA) saying on Friday that the mobility of skilled Indian talent contributes to innovation and economic growth in both countries. The new fee, announced by US President Donald Trump last week as part of measures to prevent the abuse of the H-1B visa programme -- perceived as a "national secur ...Read More >
New Delhi, Sep 26 (PTI) India and the US have decided to continue negotiations for early conclusion of a mutually beneficial bilateral trade agreement, the Commerce Ministry said on Friday. The statement was issued after the return of the Indian official delegation led by Commerce and Industry Minister Piyush Goyal to New York for trade talks. The delegation returned on September 24 after holding three-day talks. Both sides held constructive meetings on various aspects of the trade deal, the ...Read More >
Published on: September 26, 2025 5:46 PM The United States has announced a 100% tariff on Indian pharmaceutical imports, deepening trade tensions between the two countries. US President Donald Trump made the announcement on his social media platform, Truth Social. The new tariff will take effect from October 1. However, Trump said companies opening drug manufacturing plants in the US will be exempt. He cited national security as the main reason for the decision. India is among the world's larg ...Read More >
Shimla (Himachal Pradesh) [India], September 26 (ANI): The Pharmaceutical companies and chemists in Shimla have begun implementing the revised GST night tariff on medicines, bringing much-needed relief to patients and the poor. Managers and pharmacy owners in the capital confirmed that the new reforms, effective as of September 22, have already reduced the prices of many essential and life-saving medications. Mahesh Bisht, Manager at a pharmaceutical company, explained the changes, "From Septem ...Read More >
New Delhi, Sep 26 (PTI) US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only patented and branded products, not generic medicines, pharma industry players said on Friday. Indian Pharmaceutical Alliance (IPA), which represents 23 leading Indian pharmaceutical firms, including Dr Reddy's Laboratories, Sun Pharma, Lupin and Zydus Lifesciences, noted that Trump' ...Read More >
New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >
New Delhi [India], September 26 (ANI):Indian Pharmaceutical Alliance has said that the US President Donald Trump's announcement of tariffs of up to 100 per cent on imports of branded and patented pharmaceuticals starting October 1 specifically refers to patented or branded products, and not impact generic medicines. Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said, "The executive order refers to patented / branded products supplied to the US. It is not applicable to ge ...Read More >
(RTTNews) - Indian shares traded lower on Friday, extending recent losses after the Trump administration said it would impose new tariffs on heavy trucks, drugs and kitchen cabinets. The benchmark BSE Sensex was down 310 points, or 0.4 percent, at 80,847 in early trade, while the broader NSE Nifty index dropped 94 points, or 0.4 percent, to 24,797. IT stocks such as Infosys, TCS, Wipro, Tech Mahindra and HCL Technologies were down 1-2 percent after Accenture issued cautious guidance for FY26 a ...Read More >
New Delhi, Sep 26 (PTI) Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, "It is not applicable to generics medicines." Trump's statement refers to patented and branded products supplied to US, he added. In his post on social me ...Read More >
Mumbai, September 26: The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and patented pharmace ...Read More >
Mumbai: Equity benchmark indices Sensex and Nifty declined in early trade on Friday dragged by pharma stocks and relentless foreign fund outflows. US H-1B visa fee concerns and a weak trend in global markets also added to the bearish trend in domestic equities. "Investor attention will squarely be on the domestic pharma sector after the Trump Administration announced a 100 per cent tariff on imports of branded or patented pharmaceutical products effective October 1. This tariff action comes clo ...Read More >
Mumbai, Sep 26 (SocialNews.XYZ) The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and paten ...Read More >
New Delhi [India], September 26 (ANI): United States President Donald Trump announced on Friday that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies establish production facilities in the United States. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. ...Read More >
NEW DELHI: EC on Thursday revised the rules relating to counting of postal ballots, making it mandatory for all postal ballot papers to be counted before the penultimate round of EVM/VVPATs counting is taken up.The new practice will be first implemented in Bihar where assembly polls are due in Nov.This restores the arrangement prior to May 2019, when EC had changed the guidelines to allow EVM counting to proceed regardless of postal ballot counting stage. The 2019 change did not rule out chances ...Read More >
Hyderabad: Chief Minister A. Revanth Reddy on Thursday announced that the Telangana government will launch the 'Chief Minister's Breakfast Scheme' for schoolchildren in government schools starting from the 2026-27 academic year, drawing inspiration from Tamil Nadu's pioneering initiative. While attending an event organised by the Tamil Nadu government to showcase its achievements in education, nutrition, and welfare, which was attended by Tamil Nadu Chief Minister M.K. Stalin, Revanth Reddy pra ...Read More >
New Delhi, Sep 16 (SocialNews.XYZ) In a major relief for the pharma sector, the government has dismissed the mandatory rule for drug manufacturers to recall, or re-label medicines already released in the market before September 22, the Department of Pharmaceuticals said. This follows the latest revision in Goods and Services Tax (GST) rates early this month by the GST Council, which reduced the GST on medical devices to 5 per cent from 12 per cent. The National Pharmaceutical Pricing Authority ...Read More >
Gandhinagar (Gujarat) [India], September 16 (ANI): As Prime Minister Narendra Modi turns 75 on Wednesday, the nation reflects on his transformative impact on India's development. One of his most significant legacies is the Vibrant Gujarat Global Summit, a visionary initiative that was launched in 2003 during his tenure as Chief Minister of Gujarat. According to the release, this summit has been instrumental in attracting investments and fostering economic growth, ultimately enhancing Gujarat's ...Read More >
New Delhi, Sep 16 (UNI) India's merchandise exports rose to USD 35.10 billion in August 2025 compared to USD 32.29 billion in August 2024 , said the Ministry of Commerce and Industry. Moreover, the country's imports remained at USD 61.59 billion in August 2025, compared to USD 68.53 billion of the same period in previous year, showing a decline, said the statement. "The cumulative exports (merchandise and services) during April-August 2025 are estimated at USD 349.35 billion as compared to USD ...Read More >
New Delhi, Sep 13 (PTI) The National Pharmaceutical Pricing Authority has asked pharmaceutical companies and medical device makers to pass on the benefit of reduced GST rates to consumers with effect from September 22. "The benefit of reduction in GST rates shall be passed on to consumers/patients effective from September 22, 2025. All the manufacturers /marketing companies selling drugs/formulations shall revise the MRP of drugs/formulations (including medical devices) accordingly, with effect ...Read More >
Sept 12 (Reuters) - European shares slipped in choppy trading on Friday, weighed by a drop in healthcare stocks, while investors also braced for Fitch's credit rating verdict on France later in the day. After rising nearly 0.2% earlier in the day, the pan-European STOXX 600 (.STOXX), opens new tab reversed course and was last down 0.2% to 554.8 points, as of 0845 GMT. Healthcare stocks (.SXDP), opens new tab weighed the most, slipping 0.6%. Swiss pharmaceutical company Novartis (NOVN.S), opens ...Read More >
Government of India announced on Friday a special policy which benefits many Poppy cultivators. The policy has enabled 15,000 farmers this year itself. The Indian Government today announced licensing policy for cultivation of opium poppy. The policy is currently announced specifically for farmers of states of Madhya Pradesh, Rajasthan and Uttar Pradesh. The revised licensing policy is estimated to make 1.21 lakh farmers eligible for cultivating Poppy in these states - a 23 percent jump from th ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.